Background Chondrosarcomas is a rare tumour that has a variable biological characteristic. Also, their treatment clinically and surgically is controversial. We performed a comparison review of different regional institutions series with the aim of assessing the clinical outcome of patients. Purposes We, therefore, compare different institutions from different regions patients with grade 1 to 3 chondrosarcomas to (1)determine difference in survival rate, (2) local recurrence results, (3) determine successful outcome after surgery, (4) differences among surgical procedures. (5) Determine any association of clinical and demographic behaviour with gender, follow-up, treatment and chondrosarcoma affected body locations. Methods A retrospective review of 33 chondrosarcoma(all grades) patient’s data since 2013, compared with 15 author’s total 868 patients research literature to find more about clinical and statistical advantages and similarities with our study. Here is mentioning of clinical information’s, surgery type categorised, adjuvants types, genders, follow-up years, recurrence, affected areas, death rates, successful outcome and survival rates by using statistical methods. Results The overall survival rate was 94%, successful outcome 85% in 4.3 + 1.2 years follow-up. Observed wide resection, distilled water as adjuvant, chemo & radiotherapy significantly shows excellent result over our compared chondrosarcoma literature datas. We have also marked that females and humerus bone are more affected by chondrosarcoma among those literatures data. Conclusions Low-grade chondrosarcoma of the skeleton can be treated with wide resection and by the use of distilled water, which give good oncological outcome and a very low rate of post-surgical complications, as well as chondrosarcoma all grades recurrence.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.